303 related articles for article (PubMed ID: 15980336)
1. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.
Rakotomanga M; Saint-Pierre-Chazalet M; Loiseau PM
Antimicrob Agents Chemother; 2005 Jul; 49(7):2677-86. PubMed ID: 15980336
[TBL] [Abstract][Full Text] [Related]
2. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes.
Rakotomanga M; Blanc S; Gaudin K; Chaminade P; Loiseau PM
Antimicrob Agents Chemother; 2007 Apr; 51(4):1425-30. PubMed ID: 17242145
[TBL] [Abstract][Full Text] [Related]
3. Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes.
Saint-Pierre-Chazalet M; Ben Brahim M; Le Moyec L; Bories C; Rakotomanga M; Loiseau PM
J Antimicrob Chemother; 2009 Nov; 64(5):993-1001. PubMed ID: 19749205
[TBL] [Abstract][Full Text] [Related]
4. Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes.
Luque-Ortega JR; Rivas L
Antimicrob Agents Chemother; 2007 Apr; 51(4):1327-32. PubMed ID: 17283192
[TBL] [Abstract][Full Text] [Related]
5. Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.
Pérez-Victoria FJ; Castanys S; Gamarro F
Antimicrob Agents Chemother; 2003 Aug; 47(8):2397-403. PubMed ID: 12878496
[TBL] [Abstract][Full Text] [Related]
6. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
[TBL] [Abstract][Full Text] [Related]
7. Defeating Leishmania resistance to miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: a proof of mechanism for trypanosomatid chemotherapy.
Luque-Ortega JR; de la Torre BG; Hornillos V; Bart JM; Rueda C; Navarro M; Amat-Guerri F; Acuña AU; Andreu D; Rivas L
J Control Release; 2012 Aug; 161(3):835-42. PubMed ID: 22609351
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).
Seifert K; Matu S; Javier Pérez-Victoria F; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2003 Oct; 22(4):380-7. PubMed ID: 14522101
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
[TBL] [Abstract][Full Text] [Related]
10. Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine.
Armitage EG; Alqaisi AQI; Godzien J; Peña I; Mbekeani AJ; Alonso-Herranz V; López-Gonzálvez Á; Martín J; Gabarro R; Denny PW; Barrett MP; Barbas C
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463533
[TBL] [Abstract][Full Text] [Related]
11. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes.
Paris C; Loiseau PM; Bories C; Bréard J
Antimicrob Agents Chemother; 2004 Mar; 48(3):852-9. PubMed ID: 14982775
[TBL] [Abstract][Full Text] [Related]
12. Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro.
Ménez C; Buyse M; Besnard M; Farinotti R; Loiseau PM; Barratt G
Antimicrob Agents Chemother; 2006 Nov; 50(11):3793-800. PubMed ID: 16966395
[TBL] [Abstract][Full Text] [Related]
13. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death.
Mishra J; Singh S
Exp Parasitol; 2013 Oct; 135(2):397-406. PubMed ID: 23968687
[TBL] [Abstract][Full Text] [Related]
14. Cloning of S-adenosyl-L-methionine:C-24-Delta-sterol-methyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-Resistant promastigotes.
Pourshafie M; Morand S; Virion A; Rakotomanga M; Dupuy C; Loiseau PM
Antimicrob Agents Chemother; 2004 Jul; 48(7):2409-14. PubMed ID: 15215088
[TBL] [Abstract][Full Text] [Related]
15. Interaction of sitamaquine with membrane lipids of Leishmania donovani promastigotes.
Dueñas-Romero AM; Loiseau PM; Saint-Pierre-Chazalet M
Biochim Biophys Acta; 2007 Feb; 1768(2):246-52. PubMed ID: 16945323
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome.
Hendrickx S; Eberhardt E; Mondelaers A; Rijal S; Bhattarai NR; Dujardin JC; Delputte P; Cos P; Maes L
J Antimicrob Chemother; 2015 Nov; 70(11):3023-6. PubMed ID: 26253089
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
18. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Escobar P; Yardley V; Croft SL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
[TBL] [Abstract][Full Text] [Related]
19. In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization.
Shaw CD; Lonchamp J; Downing T; Imamura H; Freeman TM; Cotton JA; Sanders M; Blackburn G; Dujardin JC; Rijal S; Khanal B; Illingworth CJ; Coombs GH; Carter KC
Mol Microbiol; 2016 Mar; 99(6):1134-48. PubMed ID: 26713880
[TBL] [Abstract][Full Text] [Related]
20. Genomic Appraisal of the Multifactorial Basis for In Vitro Acquisition of Miltefosine Resistance in Leishmania donovani.
Vacchina P; Norris-Mullins B; Abengózar MA; Viamontes CG; Sarro J; Stephens MT; Pfrender ME; Rivas L; Morales MA
Antimicrob Agents Chemother; 2016 Jul; 60(7):4089-100. PubMed ID: 27114280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
